Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James Nickas"'
Autor:
James Nickas
Publikováno v:
Drug Information Journal. 31:63-70
In recent years, many important initiatives have been undertaken by regulatory authorities and industry associations to promote international harmonization of regulatory adverse event reporting requirements. Although harmonization of worldwide regula
Autor:
James Nickas
Publikováno v:
Drug Information Journal. 29:1247-1251
Two issues that are commonly debated with respect to adverse event data collection and reporting are: 1. the definitions of expected/labeled versus unexpected/unlabeled adverse events, and 2. whether to solicit and record adverse event diagnoses, sig
Publikováno v:
Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a54f842ecc5d8180cd09306603b0cba
https://doi.org/10.1002/9780470975053.ch12
https://doi.org/10.1002/9780470975053.ch12
Autor:
Amy Chen Rundle, Ann J. Johanson, James Nickas, Anna T. Meadows, David A. Graves, Thomas Moshang
Publikováno v:
The Journal of pediatrics. 128(5 Pt 2)
As of October 1993 the National Cooperative Growth Study included 1262 children with brain tumor who were treated with growth hormone. The type of brain tumor was specified in 947 (75%) of these children. The most common types were glioma, medullobla
Autor:
James Nickas
Publikováno v:
Annals of internal medicine. 103(6 ( Pt 1))
Excerpt To the editor: In the October issue, Covell and colleagues (1) discuss the need for improved and efficient systems of obtaining medical information for physicians in office practice. Their ...